Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 2393Healthcare 704Technology 382Industrials 291Financial Services 229Consumer Cyclical 183Basic Materials 152Communication Services 124Energy 114Consumer Defensive 83Real Estate 80Utilities 51
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVRXCVRx, Inc. | Healthcare | Nov 5 | Sep '26 | $14.0M | −6.7% | −$14.0M | n/m | −$0.52 | n/m | -94.3% | −10.8 pp | $17M |
| ATYRaTyr Pharma, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$18.0M | n/m | −$7.43 | n/m | — | — | $12M |
| SINTSiNtx Technologies, Inc. | Healthcare | Nov 5 | Sep '26 | $2.0M | n/m | −$2.0M | n/m | −$0.24 | n/m | -74.7% | — | $9M |
| INABIN8bio, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$0.24 | n/m | — | — | $9M |
| PHIOPhio Pharmaceuticals Corp. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.36 | n/m | — | — | $9M |
| INTSIntensity Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26pending | — | — | — | — | — | — | — | — | $7M |
| ACHAccendra Health, Inc. | Healthcare | Nov 5 | Sep '26 | $602M | −13.6% | −$20.0M | n/m | $0.00 | n/m | 0.2% | −7.9 pp | $7M |
| REVBRevelation Biosciences, Inc. | Healthcare | Nov 5 | Sep '26pending | — | — | — | — | — | — | — | — | $2M |
| NVONovo Nordisk A/S | Healthcare | Nov 4 | Sep '26 | $11.90B | +5.6% | — | −16.3% | $0.89 | −15.8% | 29.1% | −2.5 pp | $179.4B |
| MCKMcKesson Corporation | Healthcare | Nov 4 | Sep '26 | $110.96B | +7.6% | $1.22B | +9.7% | $10.44 | +17.0% | 1.4% | +0.0 pp | $126.0B |
| CVSCVS Health Corporation | Healthcare | Nov 4 | Sep '26 | $108.40B | +5.4% | $2.17B | n/m | $1.68 | n/m | 3.3% | +6.4 pp | $109.8B |
| CORCencora, Inc. | Healthcare | Nov 4 | Sep '26 | $88.36B | +5.5% | $519M | n/m | $2.71 | n/m | 1.0% | +0.0 pp | $66.9B |
| EWEdwards Lifesciences Corporation | Healthcare | Nov 4 | Sep '26 | $1.72B | +10.5% | $308M | +5.8% | $0.53 | +6.0% | 17.4% | −9.9 pp | $60.6B |
| RVMDRevolution Medicines, Inc. | Healthcare | Nov 4 | Sep '26 | $198M | n/m | −$407M | n/m | −$1.90 | n/m | -188.9% | — | $35.2B |
| MDLNMedline Inc. | Healthcare | Nov 4 | Sep '26 | $7.86B | +10.4% | $195M | −39.4% | $0.15 | −63.4% | 6.4% | −1.7 pp | $33.1B |
| RPRXRoyalty Pharma plc | Healthcare | Nov 4 | Sep '26 | $690M | +13.3% | $145M | −49.7% | $0.26 | −61.2% | 59.6% | −10.5 pp | $30.6B |
| STESTERIS plc (Ireland) | Healthcare | Nov 4 | Sep '26 | $1.59B | +8.8% | $214M | +11.5% | $2.19 | +12.9% | 18.5% | +0.2 pp | $25.0B |
| UTHRUnited Therapeutics Corporation | Healthcare | Nov 4 | Sep '26 | $833M | +4.1% | $259M | −23.6% | $5.71 | −20.3% | 37.0% | −11.7 pp | $24.9B |
| ZBHZimmer Biomet Holdings, Inc. | Healthcare | Nov 4 | Sep '26 | $2.06B | +3.1% | $192M | −16.9% | $1.00 | −13.8% | 14.9% | −2.6 pp | $19.3B |
| CRLCharles River Laboratories International, Inc. | Healthcare | Nov 4 | Sep '26 | $983M | −2.2% | $333M | +516.7% | $6.86 | +523.6% | 20.6% | +7.3 pp | $15.9B |
| BIO.BBio-Rad Laboratories, Inc. | Healthcare | Nov 4 | Sep '26 | $656M | +0.5% | $459M | n/m | $17.02 | n/m | -7.6% | −17.7 pp | $10.4B |
| QGENQiagen N.V. | Healthcare | Nov 4 | Sep '26 | $548M | +2.8% | $106M | −18.5% | $0.51 | −15.0% | 27.7% | +3.4 pp | $10.3B |
| PODDInsulet Corporation | Healthcare | Nov 4 | Sep '26 | $842M | +19.3% | $141M | +60.2% | $2.03 | +63.7% | 22.5% | +5.9 pp | $10.1B |
| BIOBio-Rad Laboratories, Inc. | Healthcare | Nov 4 | Sep '26 | $656M | +0.5% | $459M | n/m | $17.02 | n/m | -7.6% | −17.7 pp | $9.6B |
| PCVXVaxcyte, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$297M | n/m | −$1.99 | n/m | — | — | $9.4B |
| BRKRBruker Corporation | Healthcare | Nov 4 | Sep '26 | $874M | +1.5% | −$112M | n/m | −$0.81 | n/m | -10.4% | −14.5 pp | $9.4B |
| SMMTSummit Therapeutics Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$208M | n/m | −$0.26 | n/m | — | — | $8.5B |
| CYTKCytokinetics, Incorporated | Healthcare | Nov 4 | Sep '26 | $48.0M | +2,300% | −$190M | n/m | −$1.37 | n/m | -352.3% | — | $7.2B |
| CAICaris Life Sciences, Inc. | Healthcare | Nov 4 | Sep '26 | $275M | +26.7% | $15.0M | −37.5% | $0.05 | −37.5% | 7.0% | −8.0 pp | $5.7B |
| LIVNLivaNova PLC | Healthcare | Nov 4 | Sep '26 | $393M | +9.8% | $34.0M | +25.9% | $0.60 | +22.4% | 7.2% | −7.9 pp | $5.1B |
| DNTHDianthus Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $1.0M | n/m | −$47.0M | n/m | −$0.81 | n/m | — | — | $4.9B |
| GRALGRAIL, Inc. | Healthcare | Nov 4 | Sep '26 | $38.0M | +5.6% | −$104M | n/m | −$2.21 | n/m | -385.3% | −39.1 pp | $4.8B |
| OPCHOption Care Health, Inc. | Healthcare | Nov 4 | Sep '26 | $1.49B | +4.1% | $57.0M | +9.6% | $0.38 | +18.8% | 6.0% | +0.1 pp | $4.7B |
| BLLNBillionToOne, Inc. | Healthcare | Nov 4 | Sep '26 | $123M | +46.4% | $17.0M | +750.0% | $0.32 | +220.0% | 9.0% | −2.6 pp | $4.7B |
| ADPTAdaptive Biotechnologies Corporation | Healthcare | Nov 4 | Sep '26 | $84.0M | −10.6% | $3.0M | −70.0% | $0.02 | −66.7% | -0.5% | −11.5 pp | $4.6B |
| EWTXEdgewise Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | $1.17B | n/m | $9.65 | n/m | — | — | $4.5B |
| NVSTEnvista Holdings Corporation | Healthcare | Nov 4 | Sep '26 | $692M | +3.3% | $508M | n/m | $3.11 | n/m | 74.5% | +64.8 pp | $3.8B |
| RLAYRelay Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$82.0M | n/m | −$0.37 | n/m | — | — | $3.6B |
| ACHCAcadia Healthcare Company, Inc. | Healthcare | Nov 4 | Sep '26 | $895M | +5.0% | $34.0M | −5.6% | $0.38 | −5.0% | 12.7% | −1.3 pp | $3.5B |
| ARQTArcutis Biotherapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $144M | +45.5% | $9.0M | +28.6% | $0.06 | 0.0% | 6.6% | −2.0 pp | $3.5B |
| VRDNViridian Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $26.0M | −63.4% | −$101M | n/m | −$0.81 | n/m | -401.8% | −345.1 pp | $3.4B |
| ACADACADIA Pharmaceuticals Inc. | Healthcare | Nov 4 | Sep '26 | $342M | +22.6% | $54.0M | −25.0% | $0.31 | −26.2% | 20.9% | +8.1 pp | $3.2B |
| ADMAADMA Biologics Inc | Healthcare | Nov 4 | Sep '26 | $141M | +5.2% | $50.0M | +38.9% | $0.22 | +46.7% | 48.0% | +10.0 pp | $3.0B |
| PGNYProgyny, Inc. | Healthcare | Nov 4 | Sep '26 | $341M | +8.9% | $26.0M | +85.7% | $0.32 | +113.3% | 10.3% | +3.4 pp | $2.7B |
| XNCRXencor, Inc. | Healthcare | Nov 4 | Sep '26 | $117M | +457.1% | $39.0M | n/m | $0.50 | n/m | 19.6% | +245.9 pp | $2.6B |
| CLOVClover Health Investments, Corp. | Healthcare | Nov 4 | Sep '26 | $759M | +52.7% | $6.0M | n/m | $0.01 | n/m | 0.8% | +5.8 pp | $2.5B |
| ARDTArdent Health, Inc. | Healthcare | Nov 4 | Sep '26 | $1.63B | +3.0% | $45.0M | n/m | $0.31 | n/m | 5.9% | −10.3 pp | $2.5B |
| RCUSArcus Biosciences, Inc. | Healthcare | Nov 4 | Sep '26 | $9.0M | n/m | −$128M | n/m | −$1.00 | n/m | — | — | $2.4B |
| NAMSNewAmsterdam Pharma Company N.V. | Healthcare | Nov 4 | Sep '26 | $19.0M | n/m | −$17.0M | n/m | −$0.14 | n/m | -230.6% | — | $2.3B |
| PRGOPerrigo Company plc | Healthcare | Nov 4 | Sep '26 | $989M | −5.2% | −$27.0M | −437.5% | −$0.20 | −500.0% | 2.3% | −4.6 pp | $2.2B |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.